Nelson Cruz

Nelson Cruz likely to accept suspension, leaves Biogenesis-tainted agents

21 Comments

The word Wednesday was that Nelson Cruz might appeal the anticipated 50-game ban handed coming down in the Biogenesis scandal, but Jon Heyman reports that Cruz has decided to serve his time now in anticipation of becoming a free agent this winter.

It was also disclosed that Cruz is leaving the ACES agency, which represented several players expected to get Biogenesis suspensions. Yahoo! Sports’ Jeff Passan says he’s signing on with Adam Katz.

By serving the suspension now, Cruz, who is hitting .269/.330/.511 with 27 homers and 76 RBI, will certainly be a more attractive free agent this winter. Of course, teams will still be wondering how much of his bounce-back season this year was due to PED usage, even though his acquisition of Biogenesis drugs took place last year, when his rate numbers were the worst they’ve been since 2007. Or perhaps he’s simply been cheating all along.

Cruz is also bailing on the Rangers when they dearly need his bat in the middle of the order. Speculation last week was that they felt a less urgent need to trade for an outfielder because they thought he was going to appeal the suspension. The Rangers may welcome Cruz back for the postseason anyway, should they get there, but they probably will opt to go in a different direction this winter.

As for the agent switch, well, it’s no wonder than Cruz wanted to get away from ACES, which formerly represented Melky Cabrera when he was suspended and also handles Biogenesis-connected players Jhonny Peralta, Gio Gonzalez, Jesus Montero. Fautino De Los Santos and Cesar Puello, according to MLBTR’s agency database. The Brooklyn-based agency, run by brothers Seth and Sam Levinson, is or at least was being investigated by MLB for links to Biogenesis.

Update: The new names revealed in the Biogenesis scandal today — Antonio Bastardo, Sergio Escalona and Jordany Valdespin — are all ACES clients as well.

Braves sign Jacob Lindgren to one-year deal

OAKLAND, CA - MAY 29:  Jacob Lindgren #64 of the New York Yankees watches Brett Lawrie #15 of the Oakland Athletics round the bases after he hit a home run in the eighth inning at O.co Coliseum on May 29, 2015 in Oakland, California.  (Photo by Ezra Shaw/Getty Images)
Getty Images
Leave a comment

The Braves signed left-handed reliever Jacob Lindgren to a one-year deal, according to a team announcement on Sunday.

Lindgren, the Yankees’ top draft pick in 2014, was nicknamed “The Strikeout Factory” after blowing through four levels of New York’s farm system in 2014. He started the 2015 season in Triple-A Scranton/Wilkes-Barre and was called up for his major league debut only two months into the 2015 season. The 22-year-old lasted seven innings with the club before succumbing to bone chips in his elbow, and underwent bone spur surgery in June before trying his luck again during spring training in 2016.

In August, the Yankees shut Lindgren down for the remainder of the season so the lefty could undergo Tommy John surgery. With a projected return date of 2018, Lindgren was non-tendered by the Yankees on Friday.

While the Braves won’t get the benefit of Lindgren’s top prospect skill set in their bullpen anytime soon, he will remain under club control if they keep him on their 40-man roster beyond the 2017 season (per ESPN’s Keith Law).

Report: Mark Melancon is fielding several four-year, $60+ million offers

WASHINGTON, DC - OCTOBER 13: Mark Melancon #43 of the Washington Nationals works against the Los Angeles Dodgers in the eighth inning during game five of the National League Division Series at Nationals Park on October 13, 2016 in Washington, DC. (Photo by Rob Carr/Getty Images)
Getty Images
1 Comment

Free agent closer Mark Melancon is entertaining at least two offers in the four-year, $60+ million ballpark, reports FOX Sports’ Ken Rosenthal. The teams thought to be in the running are the Giants and Nationals, with the Giants having a slight edge due to their strong interest in him last summer (per ESPN’s Jerry Crasnick).

Crasnick also said that while the Giants are keeping tabs on the top three free agent closers this winter, the other two being Kenley Jansen and Aroldis Chapman, they’re leaning toward Melancon as a (slightly) more affordable option in the ‘pen. It’s worth noting that Melancon would not cost the Giants a draft pick if they decided to sign him.

Melancon had an outstanding season in 2016, nearly reaching career-best numbers with a 1.64 ERA, 2.42 FIP and 5.42 K/BB rate in 71 1/3 innings split between the Pirates and Nationals’ bullpens. The veteran right-hander earned his third career All-Star distinction after stifling opposing hitters with a 1.23 ERA and 7.9 K/9 rate in the first half, and went on to appear in his fourth consecutive playoff run.

Despite the Giants’ apparent lead in the bidding for Melancon, Rosenthal mentioned a third mystery team who might throw their hat in the ring as well. No clubs have been name-dropped as of yet.